Some issues are a result of still being paper driven as timely reports and real time information are not available, but they are not the only government agency in this scenario, only one of the most critical though. Also, some members of Congress don’t use computers either and felt uncomfortable...
Posted to
The Medical Quack .... by Barbara Duck
on 11-26-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Medical Records, Pharma, FDA, Congress, integration, CMS, Leavitt
Nothing new here in what has been posted, but this time the predictions are coming from within Ernst and Young from India. BD The Indian clinical trials market is predicted to continue its growth despite the current financial climate, according to a partner at Ernst & Young India’s Healthsciences...
Posted to
The Medical Quack .... by Barbara Duck
on 11-25-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, clinical trials, R and D, India, Economics, Outsourcing, Employment, Clinic
At first you may say this is old stuff, but the new version does much more than just take pictures on it’s way through your system, this one disperses medication, and that’s the whole idea is to have a pill put the medicine on target, where it needs to be with digestive problems such as treating Crohn...
Posted to
The Medical Quack .... by Barbara Duck
on 11-11-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Pharma, Phillips, iPill, digestive problems, crohn's disease
Will there be more Crestor for all? I am guessing the side effects of rising blood sugar levels still may need to be addressed, even with the report to determine which issue is more profound. With the cost of the product versus the generic version, this might also add some impact as to availability...
The general public as a whole are lost when it comes to the complete understanding of how a clinical trial can benefit their potential treatment plans. There is enough information on the web by all means, but how do you get the information to an individual and explain both the potential benefits...
Posted to
The Medical Quack .... by Barbara Duck
on 11-07-2008
Filed under: Medically Related, Technology, drugs, healthcare, EHR, Pharma, PHR, clinical trials, Software integration, Point of Care, Personalized Clinical Trials
New abbreviation here to become acquainted with (PGx) which is pharmacogenics, and one more move in the direction of personalized medicine by big Pharma as the marketing of blockbuster drugs slowly evolves to a new business model with genomic data input becoming a part of the process to bring new drugs...
Posted to
The Medical Quack .... by Barbara Duck
on 11-06-2008
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Pharma, Pharmacogenomics, Lilly, Pharmacogenetics
This particular statement really bothers me, is CMS now going to take on the role of “doctor here? “ The Bush administration argued that Medicare officials had the right to decide whether the expense incurred for a given item, not just the item itself, was “reasonable and necessary.” How...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, Pharma, Congress, CMS, Medicare contractor, Drug costs, Federal Court